-
Valacyclovir HydrochlorideCAS No. 124832-27-5. Molecular Formula: C13H20N6O4·HCl. Molecular Weight: 360.80 g/molread more
-
Guaifenesin DC95API:Guaifenesin DC95 Therapeutic Category:Expectorant drug Specification:Inhouse DMF:USDMF Certification:USFDA Availability:Regularly availableread more
-
Irsogladine MaleateAPI:Irsogladine Maleate CAS NO:84504-69-8 Therapeutic Category:Phosphodiesterase inhibitor Specification:Ministry standard* DMF:TPA* Certification:GMP Availability:By orderread more
-
CarvedilolCAS No. 72956-09-3. Molecular Formula: C24H26N2O4. Molecular Weight: 406.48 g/molread more
-
Memantine HydrochlorideCAS No. 41100-52-1. Molecular Formula: C12H21N.HCl. Molecular Weight: 215.76 g/molread more
-
LamotrigineCAS No.: 84057-84-1. Molecular Formula: C9H7Cl2N5. Molecular Weight: 256.09 g/molread more
-
AripiprazoleCAS Number: 129722-12-9. Molecular Formula: C23H27Cl2N3O2. Molecular Weight: 448.38 g/mol (Free base)read more
-
Moxifloxacin HydrochlorideCAS No. 186826-86-8. Molecular Formula: C21H24FN3O4 · HCl. Molecular Weight: 437.90 g/molread more
-
MarbofloxacinMarbofloxacin is a carboxylic acid derivative third generation fluoroquinolone antibiotic. It is used in veterinary medicine under the trade names Marbocyl, Forcyl, Marbo vet and Zeniquin. Aread more
Mar 21, 2022 · Generic name: alogliptin [ AL-oh-GLIP-tin ] Brand name: Nesina. Dosage form: oral tablet (12.5 mg; 25 mg; 6.25 mg) Drug class: Dipeptidyl peptidase 4 inhibitors. Medically...
The crystal structure of the free base of the antidiabetic drug alogliptin [systematic name: 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1...
1108 rows · Background. Alogliptin is a selective, orally-bioavailable inhibitor of enzymatic activity of dipeptidyl peptidase-4 (DPP-4). Chemically, alogliptin is prepared as a benzoate salt and...
Alogliptin benzoate for the treatment of type 2 diabetes. Alogliptin is an additional choice in the group of DPP-4 inhibitors. As a group, these agents have a relatively modest glucose-lowering...
Long-term (2-year) effects of alogliptin benzoate monotherapy suggest its efficacy as a new treatment strategy in diabetic HD patients. Long-term effects of alogliptin benzoate in...
Apr 10, 2015 · Alogliptin benzoate is a newly developed, highly selective DPP-4 inhibitor which has been approved in many countries throughout the world....
